Measurement of sialic acid content is insufficient to assess bioactivity of recombinant human erythropoietin

Shigehiro Yanagihara, Yuya Taniguchi, Mareto Hosono, Eiji Yoshioka, Rika Ishikawa, Yoshihiro Shimada, Toshihiko Kadoya, Kazuhiro Kutsukake

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Assessment of biological potency and its comparison with clinical effects are important in the quality control of therapeutic glycoproteins. Animal models are usually used for evaluating bioactivity of these compounds. However, alternative methods are required to simplify the bioassay and avoid ethical issues associated with animal studies. Negatively charged sialic acid residues are known to be critical for in vivo bioactivity of recombinant human erythropoietin (rhEPO). In this study, we used capillary zone electrophoresis, a chargebased separation method, to estimate the sialic acid content for predicting in vivo bioactivity of rhEPO. In vivo bioactivities of rhEPO subfractions were measured and compared with sialylation levels. The results obtained indicated that in vivo bioactivity of rhEPO is not simply correlated with the sialylation level, which suggests that it is difficult to predict biological potency from the sialic acid content alone. N-Glycan moieties as well as sialic acid residues may have a significant impact on in vivo bioactivity of rhEPO.

Original languageEnglish
Pages (from-to)1596-1599
Number of pages4
JournalBiological and Pharmaceutical Bulletin
Volume33
Issue number9
DOIs
Publication statusPublished - 2010

Fingerprint

N-Acetylneuraminic Acid
Erythropoietin
Capillary Electrophoresis
Ethics
Biological Assay
Quality Control
Polysaccharides
Glycoproteins
Animal Models

Keywords

  • Bioactivity
  • Glycoprotein
  • Quality control
  • Recombinant human erythropoietin
  • Sialic acid

ASJC Scopus subject areas

  • Pharmaceutical Science
  • Pharmacology

Cite this

Yanagihara, S., Taniguchi, Y., Hosono, M., Yoshioka, E., Ishikawa, R., Shimada, Y., ... Kutsukake, K. (2010). Measurement of sialic acid content is insufficient to assess bioactivity of recombinant human erythropoietin. Biological and Pharmaceutical Bulletin, 33(9), 1596-1599. https://doi.org/10.1248/bpb.33.1596

Measurement of sialic acid content is insufficient to assess bioactivity of recombinant human erythropoietin. / Yanagihara, Shigehiro; Taniguchi, Yuya; Hosono, Mareto; Yoshioka, Eiji; Ishikawa, Rika; Shimada, Yoshihiro; Kadoya, Toshihiko; Kutsukake, Kazuhiro.

In: Biological and Pharmaceutical Bulletin, Vol. 33, No. 9, 2010, p. 1596-1599.

Research output: Contribution to journalArticle

Yanagihara, S, Taniguchi, Y, Hosono, M, Yoshioka, E, Ishikawa, R, Shimada, Y, Kadoya, T & Kutsukake, K 2010, 'Measurement of sialic acid content is insufficient to assess bioactivity of recombinant human erythropoietin', Biological and Pharmaceutical Bulletin, vol. 33, no. 9, pp. 1596-1599. https://doi.org/10.1248/bpb.33.1596
Yanagihara, Shigehiro ; Taniguchi, Yuya ; Hosono, Mareto ; Yoshioka, Eiji ; Ishikawa, Rika ; Shimada, Yoshihiro ; Kadoya, Toshihiko ; Kutsukake, Kazuhiro. / Measurement of sialic acid content is insufficient to assess bioactivity of recombinant human erythropoietin. In: Biological and Pharmaceutical Bulletin. 2010 ; Vol. 33, No. 9. pp. 1596-1599.
@article{4de87edc42b84f448b14bbf4a7ee5595,
title = "Measurement of sialic acid content is insufficient to assess bioactivity of recombinant human erythropoietin",
abstract = "Assessment of biological potency and its comparison with clinical effects are important in the quality control of therapeutic glycoproteins. Animal models are usually used for evaluating bioactivity of these compounds. However, alternative methods are required to simplify the bioassay and avoid ethical issues associated with animal studies. Negatively charged sialic acid residues are known to be critical for in vivo bioactivity of recombinant human erythropoietin (rhEPO). In this study, we used capillary zone electrophoresis, a chargebased separation method, to estimate the sialic acid content for predicting in vivo bioactivity of rhEPO. In vivo bioactivities of rhEPO subfractions were measured and compared with sialylation levels. The results obtained indicated that in vivo bioactivity of rhEPO is not simply correlated with the sialylation level, which suggests that it is difficult to predict biological potency from the sialic acid content alone. N-Glycan moieties as well as sialic acid residues may have a significant impact on in vivo bioactivity of rhEPO.",
keywords = "Bioactivity, Glycoprotein, Quality control, Recombinant human erythropoietin, Sialic acid",
author = "Shigehiro Yanagihara and Yuya Taniguchi and Mareto Hosono and Eiji Yoshioka and Rika Ishikawa and Yoshihiro Shimada and Toshihiko Kadoya and Kazuhiro Kutsukake",
year = "2010",
doi = "10.1248/bpb.33.1596",
language = "English",
volume = "33",
pages = "1596--1599",
journal = "Biological and Pharmaceutical Bulletin",
issn = "0918-6158",
publisher = "Pharmaceutical Society of Japan",
number = "9",

}

TY - JOUR

T1 - Measurement of sialic acid content is insufficient to assess bioactivity of recombinant human erythropoietin

AU - Yanagihara, Shigehiro

AU - Taniguchi, Yuya

AU - Hosono, Mareto

AU - Yoshioka, Eiji

AU - Ishikawa, Rika

AU - Shimada, Yoshihiro

AU - Kadoya, Toshihiko

AU - Kutsukake, Kazuhiro

PY - 2010

Y1 - 2010

N2 - Assessment of biological potency and its comparison with clinical effects are important in the quality control of therapeutic glycoproteins. Animal models are usually used for evaluating bioactivity of these compounds. However, alternative methods are required to simplify the bioassay and avoid ethical issues associated with animal studies. Negatively charged sialic acid residues are known to be critical for in vivo bioactivity of recombinant human erythropoietin (rhEPO). In this study, we used capillary zone electrophoresis, a chargebased separation method, to estimate the sialic acid content for predicting in vivo bioactivity of rhEPO. In vivo bioactivities of rhEPO subfractions were measured and compared with sialylation levels. The results obtained indicated that in vivo bioactivity of rhEPO is not simply correlated with the sialylation level, which suggests that it is difficult to predict biological potency from the sialic acid content alone. N-Glycan moieties as well as sialic acid residues may have a significant impact on in vivo bioactivity of rhEPO.

AB - Assessment of biological potency and its comparison with clinical effects are important in the quality control of therapeutic glycoproteins. Animal models are usually used for evaluating bioactivity of these compounds. However, alternative methods are required to simplify the bioassay and avoid ethical issues associated with animal studies. Negatively charged sialic acid residues are known to be critical for in vivo bioactivity of recombinant human erythropoietin (rhEPO). In this study, we used capillary zone electrophoresis, a chargebased separation method, to estimate the sialic acid content for predicting in vivo bioactivity of rhEPO. In vivo bioactivities of rhEPO subfractions were measured and compared with sialylation levels. The results obtained indicated that in vivo bioactivity of rhEPO is not simply correlated with the sialylation level, which suggests that it is difficult to predict biological potency from the sialic acid content alone. N-Glycan moieties as well as sialic acid residues may have a significant impact on in vivo bioactivity of rhEPO.

KW - Bioactivity

KW - Glycoprotein

KW - Quality control

KW - Recombinant human erythropoietin

KW - Sialic acid

UR - http://www.scopus.com/inward/record.url?scp=77957575825&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77957575825&partnerID=8YFLogxK

U2 - 10.1248/bpb.33.1596

DO - 10.1248/bpb.33.1596

M3 - Article

VL - 33

SP - 1596

EP - 1599

JO - Biological and Pharmaceutical Bulletin

JF - Biological and Pharmaceutical Bulletin

SN - 0918-6158

IS - 9

ER -